HFCAS OpenIR

浏览/检索结果: 共1条,第1-1条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
A phase II study of tislelizumab plus chemotherapy in EGFR mutated advanced non-squamous NSCLC patients failed to EGFR TKI therapies: First analysis 期刊论文
ANNALS OF ONCOLOGY, 2021, 卷号: 32
作者:  Han, B.;  Tian, P.;  Zhao, Y.;  Yu, X.;  Guo, Q.;  Yu, Z.;  Zhang, X.;  Li, Y.;  Chen, L.;  Shi, X.;  Zhang, Y.;  Wang, J.
收藏  |  浏览/下载:61/0  |  提交时间:2022/01/10